Pfizer says effectiveness of COVID antiviral pill is 'beyond our wildest dreams'


A pill to treat COVID-19 from Pfizer significantly cut the risk of hospitalization and death in a clinical trial, the company has announced.
Pfizer said Friday its pill to treat COVID-19, Paxlovid, in a clinical trial was shown to reduce the risk of hospitalization or death by 89 percent when it was given within three days of the onset of symptoms, The New York Times reports. The trial consisted of participants "who are at high risk of progressing to severe illness," Pfizer said, and there were no deaths among the group treated with Paxlovid compared to 10 deaths in the placebo group, per ABC News.
Pfizer CEO Albert Bourla described the news as a "real game-changer," adding the data suggests the pill "has the potential to save patients' lives, reduce the severity of COVID-19 infections, and eliminate up to nine out of ten hospitalizations." Pfizer executive Annaliesa Anderson also told The New York Times the "results are really beyond our wildest dreams."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
At the same time, Nahid Bhadelia, founding director of the Center for Emerging Infectious Diseases Policy & Research, noted to Stat News, "The promise of oral antivirals will only be recognized if they're available at your local pharmacy, and you can afford it, and you can get the test that tells you that you're positive for COVID, so you can actually take advantage of this drug. So, the promise is there, but the rest of the pieces need to come together."
The news comes one day after Britain on Thursday became the first country to authorize an oral antiviral pill to treat COVID-19 from Merck. Merck has applied for FDA authorization in the U.S., which could come this year, according to ABC News. Pfizer said Friday it will submit its data to the Food and Drug Administration "as soon as possible," and Bourla told CNBC the company will likely do so before Thanksgiving.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
How will Wall Street react to the Trump-Powell showdown?
Today's Big Question 'Market turmoil' seems likely
By Joel Mathis, The Week US
-
Google ruled a monopoly over ad tech dominance
Speed Read Attorney General Pam Bondi hailed the ruling as a 'landmark victory in the ongoing fight to stop Google from monopolizing the digital public square'
By Peter Weber, The Week US
-
El Salvador's CECOT prison becomes Washington's go-to destination
IN THE SPOTLIGHT Republicans and Democrats alike are clamoring for access to the Trump administration's extrajudicial deportation camp — for very different reasons
By Rafi Schwartz, The Week US
-
Scientists find hint of alien life on distant world
Speed Read NASA's James Webb Space Telescope has detected a possible signature of life on planet K2-18b
By Peter Weber, The Week US
-
Katy Perry, Gayle King visit space on Bezos rocket
Speed Read Six well-known women went into lower orbit for 11 minutes
By Peter Weber, The Week US
-
Scientists map miles of wiring in mouse brain
Speed Read Researchers have created the 'largest and most detailed wiring diagram of a mammalian brain to date,' said Nature
By Peter Weber, The Week US
-
Scientists genetically revive extinct 'dire wolves'
Speed Read A 'de-extinction' company has revived the species made popular by HBO's 'Game of Thrones'
By Peter Weber, The Week US
-
Dark energy may not doom the universe, data suggests
Speed Read The dark energy pushing the universe apart appears to be weakening
By Peter Weber, The Week US
-
Why some people remember dreams and others don't
Under The Radar Age, attitude and weather all play a part in dream recall
By Chas Newkey-Burden, The Week UK
-
Pharaoh's tomb discovered for first time in 100 years
Speed Read This is the first burial chamber of a pharaoh unearthed since Tutankhamun in 1922
By Peter Weber, The Week US
-
Scientists report optimal method to boil an egg
Speed Read It takes two temperatures of water to achieve and no fancy gadgets
By Peter Weber, The Week US